Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Oct 2006

Drew W Lawrence, Miner Richard C, Marousek Gail I, Chou Sunwen

Abstract excerpt

BACKGROUND: The cytomegalovirus (CMV) UL97 inhibitor drug maribavir (MBV) is undergoing clinical antiviral trials. OBJECTIVES: To assess the MBV sensitivity of CMV strains and isolates containing mutations that confer resistance to current antiviral drugs ganciclovir, cidofovir or foscarnet. STUDY DESIGN: Resistant clinical isolates and laboratory strains containing UL97 and or UL54 DNA polymerase mutations were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzimidazoles
Share to Cytomegalovirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytosine

Share to DNA-Directed DNA Polymerase

Share to Foscarnet

Share to Ganciclovir

Share to Organophosphonates

Share to Phosphotransferases (Alcohol Group Acceptor)

Source

Identifiers

PMID: 16962820
DOI: 10.1016/j.jcv.2006.07.010

Genes

FOS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.PMID 16962820Read ↗

Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection.Semantic proximity Read ↗

Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavirSemantic proximity Read ↗

Cytomegalovirus UL97 Kinase Mutations That Confer Maribavir ResistanceSemantic proximity Read ↗

The biology of cytomegalovirus drug resistance.Semantic proximity Read ↗

Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infectionSemantic proximity Read ↗

Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants.Semantic proximity Read ↗

Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir.Semantic proximity Read ↗

Resistance of human cytomegalovirus to antiviral drugs.Semantic proximity Read ↗

The emergence of letermovir and maribavir drug-resistant mutations: from clinical trials to real-world studies.Semantic proximity Read ↗

Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir.Semantic proximity Read ↗

Drug-resistant cytomegalovirus: clinical implications of specific mutations.Semantic proximity Read ↗

Approach to drug-resistant cytomegalovirus in transplant recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.